MM&M Partner Perspectives
MM&M Partner Perspectives
Add to My Podcasts
Episodes
About
Reviews
Promote
No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
10 minutes
Posted Jul 27, 2016 at 9:20 pm.
0:00
10:38
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.
Previous
What Does Success Look Like in Patient Affordability?
Next
Adherence: Leveraging Data to Enhance Your Brand’s Ability to Reach Target Patients
← See all 4 episodes of MM&M Partner Perspectives
